logo
PATEO Deepens Collaboration with Qualcomm to Deliver New Generation Intelligent Cockpit Solution Based on Snapdragon Cockpit Elite Platform

PATEO Deepens Collaboration with Qualcomm to Deliver New Generation Intelligent Cockpit Solution Based on Snapdragon Cockpit Elite Platform

Korea Herald23-04-2025

SHANGHAI, April 23, 2025 /PRNewswire/ -- PATEO CONNECT (hereinafter referred to as "PATEO") announced today an expanded collaboration with Qualcomm Technologies, Inc. to develop PATEO's new generation intelligent cockpit solution powered by the Snapdragon ® Cockpit Elite platform. Pairing PATEO's expertise in intelligent cockpit hardware and software development with the advanced AI capabilities, excellent computing performance, and HD graphics features provided by Snapdragon Cockpit Elite (QAM8397P), PATEO's new cockpit solution will help global automakers offer top-tier intelligent cockpit products for centralized compute architectures and deliver high-performing, highly scalable, and high security cockpit solutions.
Based on Snapdragon Cockpit Elite that is powered by Qualcomm Oryon™ CPU – Qualcomm Technologies' fastest CPU now tailored for automotive workloads – and Qualcomm ® Adreno™ GPU, PATEO's new generation cockpit solution will be designed to stand out as a leader in its class, excelling in key technology areas such as multimodal interaction. With Snapdragon Cockpit Elite's accelerated AI technologies, the new solution will be positioned to usher in a new era of cockpit with the goal of creating safer, more comfortable and more intelligent drive & ride experiences for users, and contributes to the upgrade from integrating functions to "scenario-based services + intelligent emotional interaction" for intelligent cockpits. The new solution will be aimed at offering global automakers a comprehensive and upgradeable solution, encompassing both hardware architecture and software ecosystem. This will help to expedite the industry to evolve towards a "central supercomputing + zonal control" architecture.
"We're excited to join forces with PATEO and forge an expanded relationship based on our Snapdragon Cockpit Elite Platform," said Nakul Duggal, Group General Manager, Automotive, Industrial and Cloud, Qualcomm Technologies, Inc. "Together, our expertise and innovation will accelerate the implementation of advanced AI features, driving the industry toward a smarter, more efficient future."
"Qualcomm Technologies is a leader in intelligent connected vehicles, and its high-performance and open Snapdragon Cockpit Elite has laid a solid foundation for PATEO's software innovation," said Ken (Yilun) YING, Founder & Chairman of PATEO. "We look forward to accelerating the widespread adoption of cockpit-driving integration and centralized compute architecture through this collaboration, driving transformation and upgrading of vehicles from 'tools for mobility' to 'smart living space', and aiming to deliver safer, smarter mobility experiences to global users."
PATEO and Qualcomm Technologies have maintained a close collaboration. As early as 2023, PATEO became one of the first companies in China to provide intelligent cockpit solutions based on the fourth generation Snapdragon ® Cockpit Platform (QAM8295P), and secured design wins from several automakers. Currently, PATEO's new generation intelligent cockpit platform has achieved design wins for mass-production projects with two leading Chinese automakers.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HIRONIC Successfully Hosts First Asia Innovation Summit 2025
HIRONIC Successfully Hosts First Asia Innovation Summit 2025

Korea Herald

time2 days ago

  • Korea Herald

HIRONIC Successfully Hosts First Asia Innovation Summit 2025

SEOUL, South Korea, June 7, 2025 /PRNewswire/ -- HIRONIC, a global leader in non-invasive medical aesthetic technology, has successfully hosted its inaugural 'HIRONIC Innovation Summit 2025. Asia Edition' in Bangkok, Thailand on June 5th. The event brought together approximately 100 medical professionals and medical distribution industry representatives from South Korea, Thailand, Vietnam, Malaysia, Indonesia, Myanmar, and other countries. Across four in-depth clinical sessions, speakers presented the latest approaches to skin rejuvenation, covering multi-layered face and body lifting, advanced scar treatment, and next-generation needle-free drug delivery technologies. One of the keynote lectures was delivered by Dr. Wonkyu Hong, Director and dermatologist at Human Dermatology Clinic and Executive Director of the Human Clinical Trial Center in South Korea. Dr. Hong explored the rapidly evolving role of needle-free technology in aesthetic medicine, sharing his clinical experience while emphasizing both its therapeutic advantages and its significant market growth potential driven by increasing patient demand for non-invasive rejuvenation solutions. Dr. Thitikom Limrattanamekha, founder and CEO of Optima Aesthetics in Thailand and an experienced laser specialist in scar treatment, skin quality improvement, and pigmentation management, shared his expertise on combining pico laser and RF microneedling to achieve highly effective outcomes in complex scarring cases. His presentation highlighted how advanced combination protocols are reshaping non-surgical treatment approaches and expanding therapeutic options for physicians worldwide. The symposium also provided a platform to showcase the clinical advancements and growing market relevance of HIRONIC's flagship export technologies, including New Doublo™, PICOHI™, and the latest needle-free delivery system Synerjet PRO™. Sasha Borovtsova, Head of Global Marketing Office at HIRONIC, stated, "This summit not only showcased the real-world clinical applications of our technologies but also underscored the accelerating global demand for safer, more versatile, and highly effective aesthetic solutions. As innovation continues to drive market growth, HIRONIC remains committed to advancing technology and strengthening global expertise and partnerships through events like the HIRONIC Innovation Summit." Headquartered in South Korea, HIRONIC is a leading global manufacturer of medical aesthetic devices, specializing in HIFU, RF, laser, and needle-free technologies. With a presence in over 80 countries, HIRONIC has introduced iconic devices such as Doublo™, Doublo Gold™, and New Doublo 2.0™ to the international market.

Hisense Tops Global Rankings in Q1 2025 for MiniLED, 100-inch and over, and Laser TVs
Hisense Tops Global Rankings in Q1 2025 for MiniLED, 100-inch and over, and Laser TVs

Korea Herald

time3 days ago

  • Korea Herald

Hisense Tops Global Rankings in Q1 2025 for MiniLED, 100-inch and over, and Laser TVs

QINGDAO, China, June 6, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, continues to reinforce its leadership in premium display technology. According to Omdia's Q1 2025 data, Hisense ranked No.1 worldwide by volume share in 100-inch and over TVs, MiniLED TVs, and Laser TVs. Hisense led the 100-inch and over TV market with a 56.7% global volume share, ranking No. 1 in 2023, 2024, and Q1 2025. In MiniLED TVs, Hisense rose to the top with a 29.3% global volume share, reflecting rapid growth and consumer trust in its backlight innovations. Hisense also retained its lead in the Laser TV market, with a commanding 69.6% global volume share, continuing its global dominance after ranking No.1 for consecutive six years, based on Omdia data. This strong performance reflects Hisense's long-term commitment to large-screen innovation, AI-powered imaging, and immersive audio-visual experiences. Hisense was the first brand globally announced as an official partner of the FIFA Club World Cup 2025™, demonstrating its forward-looking strategy and growing international influence. Building on this milestone, Hisense launched its global campaign "Own the Moment", cementing its global leadership and connecting cutting-edge technology with the passion of sports fans worldwide. The campaign reflects Hisense's commitment to empowering unforgettable sports moments with premium technology — allowing fans to see, feel, and own the excitement like never before. Hisense has also partnered with French audio expert Devialet to enhance sound performance across its latest products, delivering a richer and more immersive home entertainment experience. These audio enhancements will be available via software update, with availability depending on specific models and regions. With a commitment to technological excellence and user value, Hisense is well-positioned to maintain its momentum in 2025 and beyond. About Hisense Hisense, founded in 1969, is a globally recognized leader in home appliances and consumer electronics with operations in over 160 countries, specializing in delivering high-quality multimedia products, home appliances, and intelligent IT solutions. According to Omdia, Hisense ranks No. 2 worldwide in total TV shipments (2022-2024) and No. 1 globally in the 100-inch and over TV segment (2023-2025Q1). As the first official partner of the FIFA Club World Cup 2025™, Hisense is committed to global sports partnerships as a way to connect with audiences worldwide.

Novogene Certified for Olink® Services Across Multiple Labs; Expands Proteomics Portfolio with Olink® Reveal
Novogene Certified for Olink® Services Across Multiple Labs; Expands Proteomics Portfolio with Olink® Reveal

Korea Herald

time3 days ago

  • Korea Herald

Novogene Certified for Olink® Services Across Multiple Labs; Expands Proteomics Portfolio with Olink® Reveal

SINGAPORE, June 5, 2025 /PRNewswire/ -- Novogene, a global leader in multi-omics solutions, is proud to announce its designation as an Olink ® Certified Service Provider (CSP) across multiple laboratories worldwide. This milestone positions Novogene among the first globally to offer high-throughput, high-quality protein biomarker discovery services using Olink's leading proteomics platforms. This multi-site certification validates Novogene's capabilities to execute Olink ® workflows with exceptional precision, consistency, and scalability across global labs—enabling advanced translational research and precision medicine for pharmaceutical, biotech, and academic partners. Novogene has broadened its suite of high-plex proteomics, with the addition of Olink ® Reveal. Olink ® Reveal enables the quantification of ~1,000 curated human proteins, including 537 inflammation markers, spanning 96% of immune response pathways and 64% of all Reactome pathways. The assay features validated, biologically relevant content enriched with cis-pQTLs—ideal for proteogenomic applications—allowing researchers to both broadly screen the proteome and deeply investigate inflammation biology. "Being certified as an Olink ® CSP across multiple Novogene labs underscores our commitment to delivering high-quality, globally harmonized data. With Olink ® Reveal offering deep insights into inflammatory biology, we empower researchers to accelerate biomarker discovery, translational research, and precision medicine. This recognition further enhances Novogene's leadership in comprehensive multi-omics solutions." said Justin Lee, Novogene VP of Global Marketing. "We are extremely excited to see Olink ® proteomics solutions being adopted by Novogene, a global provider of multi-omics solutions," said Andrea Ballagi, Olink VP of Sales and Marketing. "As part of a worldwide network of Olink ® Certified Service Providers, Novogene is well-positioned to enable scientists around the world to advance biomarker research and contribute to a healthier, cleaner and safer world". As part of the Olink ® global CSP network, Novogene is committed to deliver reproducible, high-quality data to empower the exploration of disease mechanisms, therapeutic targets, and novel biomarkers. About Novogene Novogene is a global leader in applying cutting-edge molecular biology technologies and high-performance computing to advance life science and human health research. With one of the world's largest sequencing capacities, Novogene delivers industry-leading multi-omics solutions to academic institutions, clinical researchers, and pharmaceutical companies worldwide. Driven by scientific excellence, trusted service, and uncompromising data quality, Novogene empowers researchers to accelerate discoveries across genomics, transcriptomics, proteomics, metabolomics, and beyond. As a pioneer in multi-omics, Novogene is committed to being your trusted partner in navigating the future of life science innovation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store